These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 30417304)
1. Polyunsaturated Fatty Acids and Their Correlations with Parameters of Oxidative/Antioxidant Potential of the Blood and Lipoprotein-Associated Phospholipase A2 in Coronary Atherosclerosis. Shramko VS; Polonskaya YAV; Morozov SV; Chernyak EI; Chernyavsky AM; Ragino YI Bull Exp Biol Med; 2018 Nov; 166(1):11-14. PubMed ID: 30417304 [TBL] [Abstract][Full Text] [Related]
2. Polyunsaturated omega-3 fatty acids reduce lipoprotein-associated phospholipase A(2) in patients with stable angina. Gajos G; Zalewski J; Mostowik M; Konduracka E; Nessler J; Undas A Nutr Metab Cardiovasc Dis; 2014 Apr; 24(4):434-9. PubMed ID: 24555913 [TBL] [Abstract][Full Text] [Related]
3. Gender-related and PUFA-related differences in lipoprotein-associated phospholipase A2 levels in patients with type 2 diabetes and atherosclerotic cardiovascular disease. Hanarz M; Siniarski A; Gołębiowska-Wiatrak R; Nessler J; Malinowski KP; Gajos G Adv Clin Exp Med; 2024 Jun; 33(6):593-600. PubMed ID: 37747445 [TBL] [Abstract][Full Text] [Related]
4. Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatments. Charniot JC; Khani-Bittar R; Albertini JP; Giral P; Cherfils C; Cosson C; Guillerm E; Leprince P; Gandjbakhch I; Bonnefont-Rousselot D Int J Cardiol; 2013 Sep; 168(1):132-8. PubMed ID: 23103135 [TBL] [Abstract][Full Text] [Related]
5. n-3 and n-6 Fatty acids are independently associated with lipoprotein-associated phospholipase A2 in the Multi-Ethnic Study of Atherosclerosis. Steffen BT; Steffen LM; Liang S; Tracy R; Jenny NS; Tsai MY Br J Nutr; 2013 Nov; 110(9):1664-71. PubMed ID: 23551952 [TBL] [Abstract][Full Text] [Related]
6. Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population. Ueshima H; Kadowaki T; Hisamatsu T; Fujiyoshi A; Miura K; Ohkubo T; Sekikawa A; Kadota A; Kadowaki S; Nakamura Y; Miyagawa N; Okamura T; Kita Y; Takashima N; Kashiwagi A; Maegawa H; Horie M; Yamamoto T; Kimura T; Kita T; Atherosclerosis; 2016 Mar; 246():141-7. PubMed ID: 26775119 [TBL] [Abstract][Full Text] [Related]
7. Characterization of Lipoprotein-associated Phospholipase A2 in Serum in Patients With Stage 3-5 Chronic Kidney Disease. Wang Y; Li SS; Na SP; Yu CY; Ji Y; Zhao SL; Xie RJ; Bao YS Am J Med Sci; 2016 Oct; 352(4):348-353. PubMed ID: 27776715 [TBL] [Abstract][Full Text] [Related]
8. Higher lipoprotein-associated phospholipase A2 levels are associated with coronary atherosclerosis documented by coronary angiography. Dohi T; Miyauchi K; Ohkawa R; Nakamura K; Thuboi S; Ogita M; Miyazaki T; Nishino A; Yokoyama K; Kurata T; Yatomi Y; Daida H Ann Clin Biochem; 2012 Nov; 49(Pt 6):527-33. PubMed ID: 22933444 [TBL] [Abstract][Full Text] [Related]
9. Local production of lipoprotein-associated phospholipase A2 and lysophosphatidylcholine in the coronary circulation: association with early coronary atherosclerosis and endothelial dysfunction in humans. Lavi S; McConnell JP; Rihal CS; Prasad A; Mathew V; Lerman LO; Lerman A Circulation; 2007 May; 115(21):2715-21. PubMed ID: 17502572 [TBL] [Abstract][Full Text] [Related]
10. The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma. Tellis CC; Tselepis AD Biochim Biophys Acta; 2009 May; 1791(5):327-38. PubMed ID: 19272461 [TBL] [Abstract][Full Text] [Related]
11. Differential Expression of Lipoprotein-Associated Phospholipase A2 in Monocyte Subsets: Impact of Uremia and Atherosclerosis. Ulrich C; Trojanowicz B; Fiedler R; Kohler F; Wolf AF; Seibert E; Girndt M Nephron; 2017; 135(3):231-241. PubMed ID: 27992874 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of lipoprotein-associated phosholipase A2 and plaque burden/composition in young adults. Celik O; Ozturk D; Akin F; Satilmis S; Yalcin AA; Erturk M; Ayca B; Akturk F; Birand A; Pusuroglu H; Kaya MG Coron Artery Dis; 2015 May; 26(3):266-71. PubMed ID: 25647459 [TBL] [Abstract][Full Text] [Related]
14. Lipoprotein-Associated Phospholipase A2 and Risk of Carotid Atherosclerosis and Cardiovascular Events in Community-Based Older Adults in China. Wang C; Fang X; Hua Y; Liu Y; Zhang Z; Gu X; Wu X; Tang Z; Guan S; Liu H; Liu B; Guo X; Ji X Angiology; 2018 Jan; 69(1):49-58. PubMed ID: 28429599 [TBL] [Abstract][Full Text] [Related]
15. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease. Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512 [TBL] [Abstract][Full Text] [Related]
16. Association of Lp-PLA2 with digital reactive hyperemia, coronary flow reserve, carotid atherosclerosis and arterial stiffness in coronary artery disease. Ikonomidis I; Kadoglou NN; Tritakis V; Paraskevaidis I; Dimas K; Trivilou P; Papadakis I; Tzortzis S; Triantafyllidi H; Parissis J; Anastasiou-Nana M; Lekakis J Atherosclerosis; 2014 May; 234(1):34-41. PubMed ID: 24594367 [TBL] [Abstract][Full Text] [Related]
17. Increased serum level of Lp-PLA2 is independently associated with the severity of coronary artery diseases: a cross-sectional study of Chinese population. Cai A; Li G; Chen J; Li X; Li L; Zhou Y BMC Cardiovasc Disord; 2015 Feb; 15():14. PubMed ID: 25879827 [TBL] [Abstract][Full Text] [Related]
18. Darapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, Reduces Rho Kinase Activity in Atherosclerosis. Zhang J; Xu DL; Liu XB; Bi SJ; Zhao T; Sui SJ; Ji XP; Lu QH Yonsei Med J; 2016 Mar; 57(2):321-7. PubMed ID: 26847282 [TBL] [Abstract][Full Text] [Related]
19. Lipoprotein-associated phospholipase A2: a new biomarker for cardiovascular risk assessment and potential therapeutic target. Carlquist JF; Muhlestein JB; Anderson JL Expert Rev Mol Diagn; 2007 Sep; 7(5):511-7. PubMed ID: 17892360 [TBL] [Abstract][Full Text] [Related]
20. Changes in the blood fatty-acid profile associated with oxidative-antioxidant disturbances in coronary atherosclerosis. Ragino YI; Shramko VS; Stakhneva EM; Chernyak EI; Morozov SV; Shakhtshneider EV; Polonskaya YV; Shcherbakova LV; Chernyavskiy AM J Med Biochem; 2020 Jan; 39(1):46-53. PubMed ID: 32549777 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]